Form 8-K GE HealthCare Technologi For: Feb 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
GE HealthCare (GEHC) PT Raised to $110 at Jefferies
February 13, 2025 4:30 PM ESTJefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "GEHC reported 4Q sales of $5.32B, +2% xfx (+4% ex-China) vs cons $5.32B, & EPS of $1.45 +23% vs cons $1.26. Orders... More
GE HealthCare (GEHC) PT Raised to $104 at Stifel
February 13, 2025 2:45 PM ESTStifel analyst Rick Wise raised the price target on GE HealthCare (NASDAQ: GEHC) to $104.00 (from $102.00) while maintaining a Buy rating.
The analyst comments "Following the GEHC 4Q24 call, we came away feeling encouraged about the companys 4Q24 performance and initial 2025... More
GE HealthCare (GEHC) PT Raised to $110 at Citi
February 13, 2025 2:15 PM ESTCiti analyst Joanne Wuensch raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "There was a lot to the 4Q24 against relatively low expectations, with the top-line reflecting continued pressures in China, and... More
GE HealthCare (GEHC) PT Raised to $103 at BTIG
February 13, 2025 11:38 AM ESTBTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $103.00 (from $99.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $103 (from $99) following GEHC's 4Q24 results. Rev. of $5.319B (2.0% Y/Y, 2.0% Y/Y organic) and adj. EPS of $1.45 (22.9% Y/Y)... More
